Results 111 to 120 of about 239,496 (165)

Impact of Inhibitor Development on the Cost Effectiveness of Prophylactic Treatment with Recombinant Factor VIII in Previously Untreated Patients with Severe Hemophilia A. [PDF]

Pharmacoecon Open
Yang L, Peng J, Gu C, Wang Z, Zuo G.
europepmc   +1 more source

Cost-effectiveness modeling of mortality risk reduction comparing two fixed-dose combination triple therapies in moderate-to-very severe chronic obstructive pulmonary disease. [PDF]

J Comp Eff Res
Parsekar K, Pandey S, Tansey-Dwyer D, Marshall J, Rustignoli I, Pollack M, Singh B, Ouwens M.   +7 more
europepmc   +1 more source

Cost-utility analysis of telitacicept versus belimumab in the treatment of systemic lupus erythematosus in China. [PDF]

Front Public Health
Liu C, Tao L, Yan Y, Wu Y, Wang F, Sun S.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Modeling General Practitioners’ Total Drug Costs through GAMLSS and Collective Risk Models

North American Actuarial Journal, 2022
Monitoring general practitioner prescribing costs is an important topic in order to efficiently allocate National Health Insurance resources. Using generalized additive models for location, scale, and shape with random effects, we investigate how second-order variables, related to patients, contribute to estimating the frequency, severity, and hence ...
G. P. Clemente, N. Savelli, G. A. Spedicato, D. Zappa   +3 more
openaire   +1 more source

Morbid obesity in total shoulder arthroplasty: risk, outcomes, and cost analysis

Journal of Shoulder and Elbow Surgery, 2014
A rate of obesity in the US population and the rate of total shoulder arthroplasty (TSA) has increased over the past decade. Little information exists concerning the number of morbidly obese patients undergoing TSA or how these patients compare with their non-obese counterparts.
Justin W, Griffin, Wendy M, Novicoff, James A, Browne, Stephen F, Brockmeier   +3 more
openaire   +2 more sources

Increased Risk of In-Hospital Complications and Costs After Total Hip Arthroplasty for Primary and Secondary Osteonecrosis

The Journal of Arthroplasty, 2023
An increasing proportion of patients are undergoing total hip arthroplasty (THA) for osteonecrosis (ON). Comorbid conditions and surgical risk factors are known to be greater in ON patients compared with patients who have osteoarthritis (OA) alone. The purpose of our study was to quantify the specific in-hospital complications and resource utilization ...
Gireesh B. Reddy, Julien O. Tremblay, Ramakanth R. Yakkanti, Victor H. Hernandez, Michele R. D'Apuzzo   +4 more
openaire   +2 more sources

Incidence, Risk Factors, and Costs for Hospital Returns After Total Joint Arthroplasties

The Journal of Arthroplasty, 2017
Unplanned hospital returns after total joint arthroplasty (TJA) reduce any cost savings in a bundled reimbursement model. We examine the incidence, risk factors, and costs for unplanned emergency department (ED) visits and readmissions within 30 days of index TJA.We retrospectively reviewed a consecutive series of 655 TJAs (382 total knee arthroplasty ...
Udai S, Sibia, Abigail E, Mandelblatt, Maura A, Callanan, James H, MacDonald, Paul J, King   +4 more
openaire   +2 more sources